Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgical therapy for dilated cardiomyopathy

R C Starling1, J B Young

  • 1Section of Heart Failure and Cardiac Transplant Medicine, George M. and Linda H. Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Ohio, USA. STARLIR@cesmtp.ccf.org

Cardiology Clinics
|January 19, 1999
PubMed
Summary

Dilated cardiomyopathy shows promise with medical management and potential for spontaneous improvement. New surgical therapies offer alternatives to cardiac transplantation, but require further study for patient selection and efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The diagnosis and subclassification of heart failure with preserved ejection fraction: a review.

Heart failure reviews·2026
Same author

Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

A Patient Reported Experience Measure (PREM) for use by older people in community services.

Age and ageing·2015
Same author

Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Effect of nesiritide in patients with acute decompensated heart failure.

The New England journal of medicine·2011
Same author

The effect of recipient hepatitis C virus infection on outcomes following heart transplantation.

Transplantation proceedings·2010

Area of Science:

  • Cardiology
  • Cardiovascular Medicine

Background:

  • Dilated cardiomyopathy was historically viewed as incurable and fatal.
  • Recent epidemiological data indicate spontaneous improvement in a significant portion of patients.
  • Optimal medical therapy forms the cornerstone of management for new-onset disease.

Purpose of the Study:

  • To review the evolving understanding and management of dilated cardiomyopathy.
  • To explore the role of medical therapy, mechanical support, and surgical interventions.
  • To discuss future directions in patient assessment and treatment strategies.

Main Methods:

  • Review of epidemiological studies and clinical observations.
  • Analysis of current medical treatment protocols, including beta-blockers, ACE inhibitors, and digoxin.

Related Experiment Videos

  • Evaluation of emerging surgical therapies such as cardiomyoplasty and Batista procedure, alongside left ventricular assist device (LVAD) therapy.
  • Main Results:

    • At least 25% of patients with recent-onset dilated cardiomyopathy experience spontaneous improvement.
    • Medical management, particularly with beta-blockers, offers significant benefits.
    • Surgical unloading therapies theoretically improve ventricular performance if myocyte function is intact, but patient selection remains a challenge.

    Conclusions:

    • New-onset dilated cardiomyopathy requires medical management and close monitoring.
    • Transient mechanical support can serve as a bridge to recovery.
    • Further biomolecular studies and controlled trials are essential to refine surgical techniques, optimize patient selection, and confirm the clinical benefits of novel surgical procedures compared to medical therapy and cardiac transplantation.